Bausch Health Companies Inc. (NYSE:BHC) reported its fourth-quarter results after Wednesday's closing bell. Here's a look at the details from the report.
The Details: Bausch Health Companies reported quarterly revenue of $2.56 billion which beat the analyst consensus estimate of $2.52 billion and is an increase over revenue of $2.41 billion from the same period last year.
Read Next: US, Russian Officials Begin Ukraine Peace Talks: Defense Sector Stocks Rise
“2024 was a year of delivering on our commitments, where we achieved the high-end of our revenue guidance range, and exceeded our adjusted EBITDA excluding Bausch + Lomb, and adjusted operating cash flow guidance expectations. We generated growth across all our business segments, highlighting the broad strength of our diverse portfolio that is supported by our strategic investments in the business,” said Thomas J. Appio, CEO of Bausch Health.
Outlook: Bausch Health sees fiscal 2025 revenue in a range of $9.9 billion to $10.15 billion, versus the $9.9 billion estimate, and adjusted EBITDA between $3.52 billion and $3.67 billion.
BHC Price Action: According to data from Benzinga Pro, Bausch Health shares are up 7.36% after hours at $7.00 Wednesday.
Read Next:
Image: Shutterstock
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.